Access

Article

Nature 435, 1052-1058 (23 June 2005) | doi:10.1038/nature03624; Received 8 November 2004; Accepted 12 April 2005; Published online 27 April 2005

Open Innovation Challenges

Stargazin modulates AMPA receptor gating and trafficking by distinct domains

Susumu Tomita1, Hillel Adesnik2,5, Masayuki Sekiguchi4,5, Wei Zhang3,5, Keiji Wada4, James R. Howe3, Roger A. Nicoll1,2 & David S. Bredt1

  1. Department of Physiology,
  2. Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California 94143, USA
  3. Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
  4. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  5. These authors contributed equally to this work

Correspondence to: Roger A. Nicoll1,2David S. Bredt1 Correspondence and requests for materials should be addressed to D.S.B. (Email: bredt@itsa.ucsf.edu) or R.A.N. (Email: nicoll@cmp.ucsf.edu).

Top

AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors mediate fast excitatory synaptic transmission in the brain. These ion channels rapidly deactivate and desensitize, which determine the time course of synaptic transmission. Here, we find that the AMPA receptor interacting protein, stargazin, not only mediates AMPA receptor trafficking but also shapes synaptic responses by slowing channel deactivation and desensitization. The cytoplasmic tail of stargazin determines receptor trafficking, whereas the ectodomain controls channel properties. Stargazin alters AMPA receptor kinetics by increasing the rate of channel opening. Disrupting the interaction of stargazin ectodomain with hippocampal AMPA receptors alters the amplitude and shape of synaptic responses, establishing a crucial function for stargazin in controlling the efficacy of synaptic transmission in the brain.

  1. Department of Physiology,
  2. Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California 94143, USA
  3. Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
  4. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  5. These authors contributed equally to this work

Correspondence to: Roger A. Nicoll1,2David S. Bredt1 Correspondence and requests for materials should be addressed to D.S.B. (Email: bredt@itsa.ucsf.edu) or R.A.N. (Email: nicoll@cmp.ucsf.edu).

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Neuroscience AMPA receptors get 'pickled'

Nature News and Views (02 Apr 2009)

Neuroscience An intrusive chaperone

Nature News and Views (23 Jun 2005)

See all 3 matches for News And Views